Business Context and Reporting Period
Company: Parsons Corporation (PSN)
Filing Type: Form 8-K (Current Report)
Date of Report: June 5, 2025
Event: Entry into a Material Definitive Agreement (Debt Refinancing)
Key Financial Metrics and Transaction Details
The filing details a comprehensive refinancing of the Company's existing credit facilities. No operating financial metrics (revenue, profit, cash flow) are provided in this specific filing.
| Facility Type | Amount | Maturity | Utilization |
|---|---|---|---|
| 2025 Term Loan | $450,000,000 (with $150M increase option) | 3 Years | Fully drawn on Closing Date |
| 2025 Revolving Credit Facility | $750,000,000 (with $500M increase option) | 5 Years | Not funded on Closing Date |
Interest Rates (Initial): Borrowings will bear interest at the middle of the applicable range based on leverage ratio:
- Term Loan: Term SOFR + 0.875% to 1.500% or Base Rate + 0% to 0.500%.
- Revolver: Term SOFR + 1.00% to 1.625% or Base Rate + 0% to 0.625%.
Material Changes Versus Prior Period
- Term Loan Refinancing: The new $450M Term Loan replaces the existing $350M delayed draw term loan (dated September 2022). The new facility is fully drawn, whereas the prior facility was a delayed draw.
- Revolving Credit Refinancing: The new $750M Revolver replaces the 2021 Revolving Credit Agreement. The prior agreement was paid off in its entirety on the Closing Date.
- Currency Flexibility: The new Revolver allows borrowing in multiple currencies (Sterling, Euros, CAD, AUD, Yen), whereas the prior facility terms are not explicitly detailed regarding multi-currency options in this text.
- Amortization: The new Term Loan does not require amortization payments.
Guidance, Outlook, and Risks
Use of Proceeds: Proceeds from the Term Loan were used to pay off the 2022 Delayed Draw Term Loan and for general working capital, capital expenditures, and payment of fees/expenses related to the prior revolving credit agreement. Proceeds from the Revolver are available for general corporate purposes.
Covenants and Risks: Both agreements contain customary affirmative, negative, and financial covenants, including limitations on indebtedness, liens, mergers, asset sales, and restricted payments. The interest rates are variable and dependent on the Company's consolidated leverage ratio or future debt rating.
Unusual Items: The filing does not disclose any unusual items or contingencies beyond the standard terms of the credit agreements.
Investor Verification Checklist
- Verify the exact interest rate margin applied on the Closing Date based on the Company's current leverage ratio.
- Confirm the specific financial covenant thresholds (e.g., maximum leverage ratio) in the full text of the Credit Agreements (Exhibits 10.1 and 10.2).
- Review the Company's most recent 10-Q or 10-K to assess the impact of the new debt structure on total leverage and liquidity ratios.
- Monitor future filings for any utilization of the $500M increase option on the Revolver or the $150M increase option on the Term Loan.